Romiplostim for chemotherapy-induced thrombocytopenia: Efficacy and safety of extended use.
Cy R WilkinsJocelyn OrtizLeah J GilbertShen YinJodi V MonesRekha ParameswaranSimon ManthaGerald A SoffPublished in: Research and practice in thrombosis and haemostasis (2022)
Long-term use of romiplostim for treatment of CIT was effective and safe, with no evidence of resistance or increased risk of thrombosis.
Keyphrases